Cremer, Louise M. 
ORCID: 0009-0002-1425-7352, Stemler, Jannik ORCID: 0000-0001-9152-2469, Sprute, Rosanne ORCID: 0000-0003-2457-6437, Herrmann, Sebastian ORCID: 0009-0002-2138-5176, Markus, Theresa, Salmanton-García, Jon ORCID: 0000-0002-6766-8297, Gieselmann, Lutz ORCID: 0000-0003-3699-3318, Di Cristanziano, Veronica ORCID: 0000-0003-1604-8386, Gruell, Henning ORCID: 0000-0002-0725-7138, Cornely, Oliver A. ORCID: 0000-0001-9599-3137 and Mellinghoff, Sibylle C. ORCID: 0000-0003-3928-2503
(2025).
Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024.
Blood Research, 60 (1).
pp. 1-9.
Springer Nature.
ISSN 2287-979X
![[thumbnail of s44313-025-00067-5.pdf]](http://kups.ub.uni-koeln.de/style/images/fileicons/application_pdf.png "s44313-025-00067-5.pdf") |
PDF
s44313-025-00067-5.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (1MB) |
Abstract
Introduction: COVID-19 remains a major threat to immunocompromised individuals. The determination of circulating SARS-CoV-2 antibodies in patients at high risk for severe course of SARS-CoV-2 infection is important for estimating the vaccine-induced humoral immune response. Therefore, we assessed the status quo after winter to analyze the need for booster vaccinations. Methods: Anti-spike IgG levels of 46 hospitalized patients with hematological and oncological diseases, measured between 21th December 2023 and 8th February 2024, were compared between subgroups of patients. Demographic data, underlying diseases, antineoplastic treatment, and the number of positive SARS-CoV-2 tests at the University Hospital Cologne were collected. Results: Patients with different diseases showed varying SARS-CoV-2 spike antibody levels. The highest levels were found in patients with diffuse large cell B-cell lymphoma (DLBCL) and acute leukemia who had not received specific treatment or had just initiated treatment, whereas the lowest levels were found in patients with DLBCL, acute leukemia, and multiple myeloma who had received at least one line of treatment. The geometric mean antibody titers were higher in female patients than in male patients and were highest in patients aged 41–50 years while lowest in those aged 61–70 years. Conclusion: The data presented confirm broad variations in SARS-CoV-2 anti-spike IgG levels across patients with different hematological and oncological diseases and highlight the complex interference of cancer biology, immune dysfunction, and treatment-related factors in shaping immune responses. Further research is needed to elucidate the mechanisms underlying these variations in antibody levels. We emphasize the need for regular booster vaccinations in this patient group.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code Markus, Theresa UNSPECIFIED UNSPECIFIED UNSPECIFIED |
| URN: | urn:nbn:de:hbz:38-792652 |
| Identification Number: | 10.1007/s44313-025-00067-5 |
| Journal or Publication Title: | Blood Research |
| Volume: | 60 |
| Number: | 1 |
| Page Range: | pp. 1-9 |
| Date: | 28 March 2025 |
| Publisher: | Springer Nature |
| ISSN: | 2287-979X |
| Language: | English |
| Faculty: | Central Institutions / Interdisciplinary Research Centers Faculty of Medicine |
| Divisions: | CECAD - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases Faculty of Medicine > Innere Medizin > Klinik I für Innere Medizin - Hämatologie und Onkologie Faculty of Medicine > Sonstiges > Zentrum für Klinische Studien Faculty of Medicine > Virologie > Institut für Virologie |
| Subjects: | Medical sciences Medicine |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/79265 |
https://orcid.org/0009-0002-1425-7352Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
 |
View Item |